Journal of Skin and Stem Cell

Published by: Kowsar

A Double Blind Randomized Trial of Efficacy and Safety of 5% Methimazole Versus 2% Hydroquinone in Patients with Melasma

Najmolsadat Atefi 1 , Elham Behrangi 1 , Somayyeh Nasiripour 1 , Golnaz Mehran 1 , Sedighe Naeji 1 , * , Mahba Azizi 2 , Parvaneh Hassani 1 and Zahra Azizian 2
Authors Information
1 Department of Dermatology, Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
2 Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Journal of Skin and Stem Cell: March 2017, 4 (2); e62113
  • Published Online: December 20, 2016
  • Article Type: Research Article
  • Received: October 6, 2016
  • Revised: November 23, 2016
  • Accepted: December 10, 2016
  • DOI: 10.5812/jssc.62113

To Cite: Atefi N, Behrangi E, Nasiripour S, Mehran G, Naeji S, et al. A Double Blind Randomized Trial of Efficacy and Safety of 5% Methimazole Versus 2% Hydroquinone in Patients with Melasma, J Skin Stem Cell. 2017 ; 4(2):e62113. doi: 10.5812/jssc.62113.

Copyright © 2016, Journal of Skin and Stem Cell. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Sanchez NP, Pathak MA, Sato S, Fitzpatrick TB, Sanchez JL, Mihm MJ. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol. 1981;4(6):698-710. [PubMed: 6787100].
  • 2. Hexsel D, Rodrigues TC, Dal. Forno T, Zechmeister-Prado D, Lima MM. Melasmaandpregnancy in southern Brazil. J Eur AcadDermatol Venereol. 2009;23(3):367-8.
  • 3. Briganti S, Camera E, Picardo M. Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res. 2003;16(2):101-10. [PubMed: 12622786].
  • 4. Lee J, Jung E, Lee J, Huh S, Boo YC, Hyun CG, et al. Mechanisms of melanogenesis inhibition by 2,5-dimethyl-4-hydroxy-3(2H)-furanone. Br J Dermatol. 2007;157(2):242-8. doi: 10.1111/j.1365-2133.2007.07934.x. [PubMed: 17650175].
  • 5. Solano F, Briganti S, Picardo M, Ghanem G. Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. Pigment Cell Res. 2006;19(6):550-71. doi: 10.1111/j.1600-0749.2006.00334.x. [PubMed: 17083484].
  • 6. Sheth VM, Pandya AG. Melasma: a comprehensive update: part II. J Am Acad Dermatol. 2011;65(4):699-714. quiz 715. doi: 10.1016/j.jaad.2011.06.001. [PubMed: 21920242].
  • 7. Draelos ZD. Skin lightening preparations and the hydroquinone controversy. Dermatol Ther. 2007;20(5):308-13. doi: 10.1111/j.1529-8019.2007.00144.x. [PubMed: 18045355].
  • 8. Nazzaro-Porro M. Azelaic acid. J Am Acad Dermatol. 1987;17(6):1033-41. [PubMed: 2963038].
  • 9. Balina LM, Graupe K. The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol. 1991;30(12):893-5. [PubMed: 1816137].
  • 10. Godse DK. Approach to melasma in India. 2014, [cited Sept 8]. Available from:
  • 11. Marta Rendon MB, Arellano I, Picardo M. Treatment of melasma. 2014, [cited Sept 8]. Available from:
  • 12. Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg. 1999;25(1):18-22. [PubMed: 9935087].
  • 13. Sarkar R, Kaur C, Bhalla M, Kanwar AJ. The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: a comparative study. Dermatol Surg. 2002;28(9):828-32. discussion 832. [PubMed: 12269877].
  • 14. Wang CC, Hui CY, Sue YM, Wong WR, Hong HS. Intense pulsed light for the treatment of refractory melasma in Asian persons. Dermatol Surg. 2004;30(9):1196-200. doi: 10.1111/j.1524-4725.2004.30371.x. [PubMed: 15355358].
  • 15. Malek J, Chedraoui A, Nikolic D, Barouti N, Ghosn S, Abbas O. Successful treatment of hydroquinone-resistant melasma using topical methimazole. Dermatol Ther. 2013;26(1):69-72. doi: 10.1111/j.1529-8019.2012.01540.x. [PubMed: 23384022].
  • 16. Kasraee B. Depigmentation of brown Guinea pig skin by topical application of methimazole. J Invest Dermatol. 2002;118(1):205-7. doi: 10.1046/j.0022-202x.2001.01621.x. [PubMed: 11851896].
  • 17. Kasraee B, Handjani F, Parhizgar A, Omrani GR, Fallahi MR, Amini M, et al. Topical methimazole as a new treatment forpostinflammatory hyperpigmentation: report of the first case. Dermatol. 2005;211:360-2.
  • 18. Kasraee B, Hugin A, Tran C, Sorg O, Saurat JH. Methimazole is an inhibitor of melanin synthesis in cultured B16 melanocytes. J Invest Dermatol. 2004;122:1338. 41.
  • 19. Engler H, Taurog A, Luthy C, Dorris ML. Reversible and irreversible inhibition of thyroid peroxidase-catalyzed iodination by thioureylene drugs. Endocrinology. 1983;112(1):86-95. doi: 10.1210/endo-112-1-86. [PubMed: 6847836].
  • 20. Saito K, Yamamoto K, Takai T, Yoshida S. The sodium-dependent iodide transportby phospholipid vesicles reconstituted with the thyroid plasma membrane. J Biochem. 1982;92:2001-7.
  • 21. Shiroozu A, Taurog A, Engler H, Dorris ML. Mechanism of action of thioureylene antithyroid drugs in the rat: possible inactivation of thyroid peroxidase by propylthiouracil. Endocrinology. 1983;113(1):362-70. doi: 10.1210/endo-113-1-362. [PubMed: 6861708].
  • 22. Kasraee B. Peroxidase-mediated mechanisms are involved in the melanocytotoxic and melanogenesis-inhibiting effects of chemical agents. Dermatology. 2002;205(4):329-39. doi: 10.1159/000066439. [PubMed: 12444326].
  • 23. Andrawis A, Kahn V. Effect of methimazole on the activity of mushroomtyrosinase. Biochem J. 1986;235:91-6.
  • 24. Hanlon DP, Shuman S. Copper ion binding and enzyme inhibitory properties of the antithyroid drug methimazole. Experientia. 1975;31(9):1005-6. [PubMed: 809293].
  • 25. Gaskell M, McLuckie KI, Farmer PB. Genotoxicity of the benzene metabolites para-benzoquinone and hydroquinone. Chem Biol Interact. 2005;153-154:267-70. doi: 10.1016/j.cbi.2005.03.034. [PubMed: 15935826].
  • 26. Kasraee B, Safaee Ardekani GH, Parhizgar A, Handjani F, Omrani GR, Samani M, et al. Safety of topical methimazole for the treatment of melasma. Transdermal absorption, the effect on thyroid function and cutaneous adverse effects. Skin Pharmacol Physiol. 2008;21(6):300-5. doi: 10.1159/000148222. [PubMed: 18667842].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments